HKR International Limited (“the Company”) announced today the annual results of the Company and its subsidiaries (“the Group”) for the financial year ended 31 March 2022 (“the Year”).
The Group’s revenue and underlying net profit (excluding net unrealised gains on fair value of investment properties) for the Year reached HK$4,167.9 million and HK$960.4 million, representing increases of 9.4% and 10.6% as compared to HK$3,809.5 million (restated) and HK$868.6 million for the preceding year respectively. Profit attributable to shareholders for the Year was HK$1,097.3 million, increased by 22.3% as compared with HK$897.3 million in the preceding year.
With the Group’s disposal of all the medical businesses, the segment results of healthcare of HK$27.5 million was reclassified as discontinued operation and the Group’s profit attributable to shareholders from continuing operations was HK$1,069.8 million, increased by 20.6% as compared to that for the preceding year.
Basic earnings per share of the Group from both continuing and discontinued operations, and from continuing operations were HK73.9 cents (2021: HK60.4 cents) and HK72.0 cents (2021: HK59.7 cents). Both increased by 22.3% and 20.6% respectively. As at 31 March 2022, the net asset value attributable to shareholders of the Company stood at HK$25,026.9 million (HK$16.8 per share), as compared with HK$23,683.9 million (HK$15.9 per share) in the preceding year.
The Board of Directors recommended a final dividend of HK5 cents per share for the Year. This, alongside the interim dividend of HK3 cents per share, makes up a total dividend of HK8 cents per share for the Year. In the preceding year, a total dividend of HK9 cents per share was paid to shareholders.
The full results announcement is available on the Group’s corporate website (www.hkri.com), under the section of “Investor Relations”, and on the “HKExnews” website (www.hkexnews.hk) of the Hong Kong Exchanges and Clearing Limited.
About HKR International Limited
HKR International Limited has diversified interests in real estate development and investment, property management, luxury hotels and serviced apartments, and other investments in Hong Kong, mainland China and across Asia.
The Company’s diverse portfolio includes Discovery Bay and CDW Building in Hong Kong, HKRI Taikoo Hui in Shanghai, and a number of premium residential properties under development in Shanghai, Jiaxing and Hangzhou. HKRI has been listed on The Stock Exchange of Hong Kong since 1989, under the Stock Code of 00480.